Periodicidad semestral: flujo continuo.
ISSN - Electrónico: 2661-6947 / DOI: 10.36015 • LILACS BIREME (19784); LATINDEX (20666)
Neuromuscular relaxation is one of the four components in General Anesthesia, depending on the surgical procedure is warranted different degrees. Rocuronium has a favorable profile for its short latency and acceptable safety profile, however the completion of its effect is not controllable. The discovery of sugammadex has changed this factor and changed the anesthetic
management, dose-dependent manner allows us to reverse from moderate to intense and by monitoring with great security as evidenced in RCTs and meta-analysis. Rocuronium allows us to
perform rapid sequence induction comparable to succinylcholine and sugammadex reduces the risk of residual relaxation and prolonged mechanical ventilation. It is important to emphasize its
application in obstetric patients, elderly, neuromuscular diseases and in patients with renal failure and pediatric population.
Welliver M. Discovery, development, and clinical application of sugammadex sodium, a selective relaxant binding agent, Drug Design, Development Therapy, 2008; 2:49–59
Arezou Sadighi Akha. Sugammadex: Cyclodextrins, Development of Selective Binding Agents, Pharmacology,
Clinical Development, and Future Directions. Anesthesiology Clin, 2010; 28:691–708
Rex C, Wagner S, Spies C, Scholz J, Rietbergen H, Heeringa M, WulfH. Reversal of neuromuscular blockade by sugammadex after continuous infusion of rocuronium in patients randomized to sevoflurane or propofol maintenance anesthesia. Anesthesiology, 2009; 111(1):30-5
Sorensen MK, Bretlau C, Gatke MR, Sorensen AM, Rasmussen LS. Rapid sequence induction and intubation with rocuronium - sugammadex compared with succinylcholine: A randomized trial, EBM Reviews - Cochrane Central Register of Controlled Trials British J Anaesthesia, 2012; 108(4):682-689
De Kam P-J, Grobara P, Dennie J, Cammu G, Ramael S, Jagt-Smook MLF, Van Den Heuvel MW, Berg RJW, Peeters PAM. Effect of sugammadex on QT/QTc interval prolongation when combined with QTc-prolonging sevoflurane or propofolanaesthesia. Clinical Drug Invest, 2013; 33 (8):545-551.
Aaron F. Kopman, M.D. Neostigmine versus Sugammadex, Which, When and How Much? Anesthesiology, 2010; 113:1010–1
Schaller SJ, Sugammadex and neostigmine dose-finding study for reversal of shallow residual neuromuscular block. Anesthesiology, 2010; 113(5):1054-60.
Kotake Y, Ochiai R, Suzuki T, Ogawa S, Takagi S, Ozaki M, Nakatsuka I, Takeda. Reversal with sugammadex in the absence of monitoring did not preclude residual neuromuscular block. J Anesth Analg, 2013; 117(2):345-51
Sabater FJ. Cost effectiveness of sugammadex in the management of patients with unanticipated difficult intubation and patients needing rapid sequence intubation
A. G. Ackerman. Availability and storage of sugammadex for emergency use. Anaesthesia, 2011; 66:132–143
Paton L, Gupta S, Blacoe D. Successful use of sugammadex in a ‘can’t ventilate’ scenario. Anaesthesia, 2013; 68(8):861-4
McDonagh D, Benedict P, Kovac A, et.al. Efficacy, Safety, and Pharmacokinetics of Sugammadex for the Reversal of Rocuronium-induced Neuromuscular Blockade in Elderly Patients. Anesthesiology, 2011; 114:2-11
Staals LM, Snoeck MMJ, Drissen JJ, et al. Multicentre, parallelgroup, comparative trial evaluating the efficacy and safety of sugammadex in patients with end-stage renal failure or normal renal function. Br J Anaesth, 2008;101(4):492-497
Machado de Souza C, Navarro Garcia N, Parreño Caparros M,Veiga Ruiz G, Tardelli MA, Alvarez-Gomez. Efficacy of sugammadex in reversal profound rocuronium-induced blockade in patients with end-stage renal disease submitted to renal transplantation, J.A. Hospital do Rim e Hipertensâo–Fundaçâo Oswaldo, 2010.
Loupec T, Lacroix C, Dhoste K, Debaene P. Sugammadex dosage based on ideal body weight for profound rocuronium-induced neuromuscular blockade reversal in morbidly obese patients. Anaesthesia, 2012; 68:811-5
Van Lancker P, Dillemans B, Bogaert T, Mulier JP, De Kock M, Haspeslagh M, Ideal versus corrected body weight for dosage of sugammadex in morbidly obese patients, Anaesthesia, 2011; 66(8):721-5
Carron M, Veronese S, Foletto M, Ori C. Sugammadex allows fast-track bariatric surgery. Obesity Surgery, 2013;23(10):1558-1563
Van Lancker P, Dillemans B, Bogaert T, Mulier JP, De Kock M, Haspeslagh M. Ideal versus corrected body weight for dosage of sugammadex in morbidly obese patients, Anaesthesia, 2011;66(8):721-5
Llauradó S, Sabaté A, Ferreres E, Camprubí I, Cabrera A. Sugammadex ideal body weight dose adjusted by level of neuromuscular blockade in laparoscopic bariatric surgery. Anesthesiology, 2012; 117(1):93-97
Veiga Ruiz G, Carceles B, Dominguez Serrano N, Lopez Fuentes L, Orozco Montes J, Alvarez-Gomez JA. Sugammadex reversal efficacy and security vs neostigminein the rocuronium - induced neuromuscular blockade in paediatric patients. Ped Anaesth Intensive Care, 2010.
Plaud B, Meretoja O, Hofmockel R, Raft J, Stoddart PA, van Kuijk JH, Hermens Y, Mirakhur RK. Reversal of rocuroniuminduced neuromuscular blockade with sugammadex in pediatric and adult surgical patients. Anesthesiology, 2009; 110(2):284-9
Takashi K. Successful management of rocuronium-induced anaphylactic reactions with sugammadex: a case report. J Clin Anesthesia, 2011; 28:35-40
Unterbuchner C, Fink M. The use of sugammadex in a patient with myasthenia gravis. Anaesthesia, 2010; 35:27-40
De Boer H, Esmond JA, Driessen B. Reversal of rocuroniuminduced profound neuromuscular block by sugammadex in Duchenne muscular dystrophy, Pediatric Anesthesia, 2009; 19:1226–1228
Weekes G, Hayes N, Bowen M. Reversal of prolonged rocuronium neuromuscular blockade with sugammadex in an obstetric patient with transverse myelitis. Elsevier, 2010.
Williamson R, Mallaiah S, Barclay P. Rocuronium and Sugammadex for Rapid Sequence Induction of Obstetric General Anesthesia. Acta Anaesthesiol Scand, 2011;55(6):694–699
Nagai M, Kasuya Y, Komayama N, Nakayama H, Ozaki M. Rocuronium and sugammadex for electroconvulsive
therapy, Tokyo Women’s Medical University, Department of Anaesthesiology, 2011, Tokyo, Japan.
Calado F. Reversal of neuromuscular blockade with sugammadex. Cost-effectiveness analysis. Anaesthesia, 2010; 23:35-39
Girish P. New Concepts in Neuromuscular blockade: Emphasis on Postoperative Residual Paralysis, 2012.
Cammu G, De Witte J, De Veylder J, et, Posoperative residual Paralysis in outpatients versus inpatients. Anesthanalg, 2006; 102: 426-9
Murphy GS, Szokol JW, Marymont JH et al: Residual Neuromuscular Blockade and Critical Respiratory events in the post anesthesia care unit. Anesthanalg, 2008; 107:130-7
MirakhurRK. Sugammadex in clinical practice. Anaesthesia, 2009; 64(1):45-54
Adrienn P, Szilárd S, Réka N, et. al. Sugammadex at the Reappearance of Four Twitches to Train-of-four Stimulation. Anesthesiology, 2013; 119:36-42
The authors who publish in this journal accept the following conditions:
1. The authors retain the copyright and grant to the CAMbios MEDICAL-SCIENTIFIC JOURNAL HECAM the right of the first publication, with the work registered with the Creative Commons attribution license, which allows third parties to use the published material provided that they mention the authorship of the work and the first publication in this journal.
2. Authors can make other independent and additional contractual agreements for the non-exclusive distribution of the version of the article published in this journal (for example, include it in an institutional repository or publish it in a book) as long as it clearly indicates that the work was published. for the first time in the CAMbios MEDICAL-SCIENTIFIC JOURNAL HECAM.